MLYS Annual Accounts Payable
$601.00 K
-$1.31 M-68.48%
31 December 2023
Summary:
As of January 23, 2025, MLYS annual accounts payable is $601.00 thousand, with the most recent change of -$1.31 million (-68.48%) on December 31, 2023. During the last 3 years, it has risen by +$72.00 thousand (+13.61%). MLYS annual accounts payable is now -68.48% below its all-time high of $1.91 million, reached on December 31, 2022.MLYS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MLYS Quarterly Accounts Payable
$3.11 M
+$1.40 M+81.96%
30 September 2024
Summary:
As of January 23, 2025, MLYS quarterly accounts payable is $3.11 million, with the most recent change of +$1.40 million (+81.96%) on September 30, 2024. Over the past year, it has increased by +$2.50 million (+416.81%). MLYS quarterly accounts payable is now -44.27% below its all-time high of $5.57 million, reached on September 30, 2023.MLYS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MLYS Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.5% | +416.8% |
| 3 y3 years | +13.6% | +41.4% |
| 5 y5 years | +13.6% | +41.4% |
MLYS Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -68.5% | at low | -44.3% | +416.8% |
| 5 y | 5-year | -68.5% | +13.6% | -44.3% | +416.8% |
| alltime | all time | -68.5% | +13.6% | -44.3% | +416.8% |
Mineralys Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.11 M(+82.0%) |
| June 2024 | - | $1.71 M(-59.9%) |
| Mar 2024 | - | $4.26 M(+609.0%) |
| Dec 2023 | $601.00 K | $601.00 K(-89.2%) |
| Sept 2023 | - | $5.57 M(+153.8%) |
| June 2023 | - | $2.20 M(-8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $2.39 M(+25.2%) |
| Dec 2022 | $1.91 M(+149.9%) | $1.91 M(-25.6%) |
| Sept 2022 | - | $2.56 M(+235.9%) |
| Dec 2021 | $763.00 K(+44.2%) | - |
| Dec 2021 | - | $763.00 K |
| Dec 2020 | $529.00 K | - |
FAQ
- What is Mineralys Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual accounts payable year-on-year change?
- What is Mineralys Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly accounts payable year-on-year change?
What is Mineralys Therapeutics annual accounts payable?
The current annual accounts payable of MLYS is $601.00 K
What is the all time high annual accounts payable for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual accounts payable is $1.91 M
What is Mineralys Therapeutics annual accounts payable year-on-year change?
Over the past year, MLYS annual accounts payable has changed by -$1.31 M (-68.48%)
What is Mineralys Therapeutics quarterly accounts payable?
The current quarterly accounts payable of MLYS is $3.11 M
What is the all time high quarterly accounts payable for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly accounts payable is $5.57 M
What is Mineralys Therapeutics quarterly accounts payable year-on-year change?
Over the past year, MLYS quarterly accounts payable has changed by +$2.50 M (+416.81%)